Shukra Pharmaceuticals Allots 1.17 Million Shares Upon Promoter Warrant Conversion
Shukra Pharmaceuticals Ltd 路 Outcome 路 03 Sept 2026, 12:23 am
Shukra Pharmaceuticals Allots 1.17 Million Shares Upon Promoter Warrant Conversion On 2nd Sep'26, Shukra Pharmaceuticals allotted 11.73 lakh equity shares to promoter Navkar Surgical Gujarat Ltd following warrant conversion. By receiving the 75% balance of Rs.26.67 per share against the Rs.35.56 issue price, the company raised Rs.3.13 crore. Consequently, paid-up equity capital increased to Rs.44.08 crore, while Navkar's post-diluted holding rose from 11.78% to 11.93%. Following this tranche, 17.35 lakh warrants remain outstanding for future conversion from the original 28th Jan'26 preferential allotment.
Original exchange filing (PDF)
More announcements from Shukra Pharmaceuticals Ltd
- Approval for Change of Name of Company on National Stock Exchange Limited dated 16th November 2026 路 17 Nov 2026
- Media Release 路 05 Nov 2026
- Shukra Pharmaceuticals Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026. 路 05 Nov 2026
- Reg 32 路 05 Nov 2026
- Unaudited financial results for the quarter ended 30th September 2026 路 05 Nov 2026
- Unaudited financial results for the quarter ended 30th September 2026 路 05 Nov 2026
- SHUKRA PHARMACEUTICALS LIMITED has informed the Exchange about Board Meeting to be held on 04-Nov-2026 to inter-alia consider and approve the Unaudited Financial results of the Company for the Quarterly ended September 2026 . 路 04 Nov 2026
- The Board Meeting to be held on 03/11/2026 has been revised to 04/11/2026 The Board Meeting to be held on 03/11/2026 has been revised to 04/11/2026 路 04 Nov 2026
